| Literature DB >> 28912725 |
Beatriz Bachero-Mena1,2, Fernando Pareja-Blanco1,2, Juan J González-Badillo2.
Abstract
The purpose of this study was to analyze changes in sprint, strength, hematological, and hormonal parameters in high-level 800 m athletes during a complete athletics season. Thirteen male athletes of national and international level in 800 m (personal best ranging from 1:43 to 1:58 min:ss) participated in this study. A total of 5 tests were conducted during a complete athletics season. Athletes performed sprint tests (20 and 200 m), countermovement jump (CMJ), jump squat (JS), and full squat (SQ) tests. Blood samples (red and white blood profile) and hormones were collected in test 1 (T1), test 3 (T3), and test 5 (T5). A general increase in the performance of the strength and sprint parameters analyzed (CMJ, JS, SQ, 20 m, and 200 m) during the season was observed, with a significant time effect in CMJ (P < 0.01), SQ (P < 0.01), and 200 m (P < 0.05). This improvement was accompanied by a significant enhancement of the 800 m performance from T3 to T5 (P < 0.01). Significant changes in some hematological variables: hematocrit (Hct) (P < 0.01), mean corpuscular volume (MCV) (P < 0.001), mean corpuscular hemoglobin content (MCHC) (P < 0.001), white blood cells count (WBC) (P < 0.05), neutrophils (P < 0.05), monocytes (P < 0.05), and mean platelet volume (MPV) (P < 0.05) were observed throughout the season. The hormonal response and creatin kinase (CK) did not show significant variations during the season, except for insulin-like growth factor I (IGF-1) (P < 0.05). In conclusion, our results suggest the importance of strength levels in middle-distance athletes. On the other hand, variations in some hematological parameters and a depression of the immune system occurred during the season. Therefore, monitoring of the mechanical, hematological and hormonal response in athletes may help coaches and athletes to optimize the regulation of training contents and may be useful to diagnose states of overreaching or overtraining in athletes throughout the season.Entities:
Keywords: IGF-1; competition; countermovement jump; hematocrit; middle-distance; resistance-training
Year: 2017 PMID: 28912725 PMCID: PMC5583192 DOI: 10.3389/fphys.2017.00637
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Figure 1Overview of the experimental design. A total of five tests were spread over the athletics season. Strength and sprint tests were performed in all the tests. Blood samples were collected in T1, T3, and T5. Eight-hundred meter performance was recorded in T3 and T5.
Changes in strength and running variables during a complete athletics season in 800 m high-level athletes.
| CMJ (cm) | 40.0 ± 6.2 | 40.0 ± 6.6 | 40.9 ± 7.4 | 41.9 ± 5.9 | 43.0 ± 6.4 |
| JS (cm) | 21.3 ± 2.7 | 21.9 ± 2.9 | 22.6 ± 3.8 | 22.9 ± 3.4 | 23.0 ± 4.2 |
| SQ (m· | 1.19 ± 0.07 | 1.23 ± 0.09 | 1.26 ± 0.10 | 1.32 ± 0.05 | 1.28 ± 0.05 |
| 20 m (s) | 2.93 ± 0.10 | 2.92 ± 0.11 | 2.92 ± 0.10 | 2.91 ± 0.08 | 2.88 ± 0.06 |
| 200 m (s) | – | 24.12 ± 1.13 | 23.89 ± 1.36 | 23.48 ± 0.86 | 23.26 ± 1.03 |
| 800 m (s) | – | – | 115.50 ± 4.77 | – | 113.79 ± 4.14 |
P < 0.05;
P < 0.01;
P < 0.001 (significant differences respect to T1);
P < 0.05;
P < 0.01; (significant differences respect to T2);
P < 0.05;
P < 0.01; (significant differences respect to T3). Time effect:
P < 0.05;
P < 0.01. CMJ, countermovement jump; JS, jump squat; SQ, average velocity attained with common loads in full squat test; 20 m, time achieved in 20 m sprint; 200 m, time achieved in 200 m sprint; 800 m, time achieved in 800 m running.
Changes in hematological parameters during a complete athletics season in 800 m high-level athletes.
| RBC (mill·mm3) | 5.05 ± 0.41 | 5.14 ± 0.29 | 5.09 ± 0.38 | ||
| Hb (g·dl−1) | 15.11 ± 0.75 | 15.32 ± 0.64 | 15.46 ± 0.88 | ||
| Hct (%) | 43.83 ± 2.32 | 44.86 ± 1.51 | 42.64 ± 2.11 | ||
| MCV (fl) | 87.04 ± 4.73 | 87.52 ± 4.21 | 84.02 ± 3.64 | ||
| MCH (pg) | 30.10 ± 1.71 | 30.22 ± 1.16 | 30.50 ± 1.78 | ||
| MCHC (%) | 34.49 ± 1.18 | 34.17 ± 1.36 | 36.26 ± 1.08 | ||
| RDW (%) | 12.72 ± 0.53 | 12.77 ± 0.41 | 12.81 ± 0.50 | ||
| WBC (mil·uL−1) | 6.78 ± 1.92 | 6.83 ± 2.24 | 5.92 ± 1.65 | ||
| Neutrophils (mil·uL−1) | 3.51 ± 1.42 | 3.58 ± 1.45 | 2.91 ± 0.92 | ||
| Lymphocytes (mil·uL−1) | 2.48 ± 1.03 | 2.46 ± 0.83 | 2.32 ± 0.73 | ||
| Monocytes (mil·uL−1) | 0.59 ± 0.18 | 0.61 ± 0.18 | 0.52 ± 0.13 | ||
| Eosinophils (mil·uL−1) | 0.16 ± 0.08 | 0.14 ± 0.07 | 0.14 ± 0.07 | ||
| Basophils (mil·uL−1) | 0.03 ± 0.05 | 0.03 ± 0.05 | 0.05 ± 0.05 | ||
| Platelets (mil·mm3) | 224.38 ± 56.62 | 225.15 ± 57.00 | 209.77 ± 56.83 | ||
| MPV (fl) | 11.34 ± 1.03 | 11.34 ± 1.01 | 11.68 ± 1.15 |
P < 0.05;
P < 0.001 (respect to T1);
P < 0.05;
P < 0.01;
P < 0.001 (respect to T3). Time effect:
P < 0.05;
P < 0.01;
P < 0.001. RBC, red blood cell count; Hb, hemoglobin; Hct, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin content; RDW, red blood cell distribution width; WBC, white blood cells count; MPV, mean platelet volume.
Changes in biochemical and hormonal response during a complete athletics season in 800 m high-level athletes.
| CK (U·L−1) | 234.1 ± 142.6 | 257.9 ± 101.6 | 202.0 ± 111.5 | ||
| PRL (ng·ml−1) | 11.1 ± 6.0 | 12.3 ± 6.0 | 12.5 ± 4.3 | ||
| GH (μg·L−1) | 0.75 ± 0.94 | 0.74 ± 1.66 | 0.56 ± 1.31 | ||
| IGF-1 (nmol·L−1) | 37.7 ± 12.5 | 36.4 ± 12.7 | 33.8 ± 3.2 | ||
| C (nmol·L−1) | 367.8 ± 98.5 | 322.8 ± 77.8 | 347.9 ± 88.6 | ||
| T (nmol·L−1) | 19.4 ± 4.4 | 18.3 ± 4.8 | 20.6 ± 6.7 |
P < 0.05 (respect to T1). Time effect:
P < 0.05. CK, creatin kinase; PRL, prolactin; GH, human growth hormone; IGF-1, insulin-like growth factor I; C, cortisol; T, testosterone.